van deVen C - Search Results

1

An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients.

Bhatia M, Militano O, Jin Z, Figurski M, Shaw L, Moore V, Morris E, Tallamy B, van deVen C, Ayello J, Baxter-Lowe L, Satwani P, George D, Bradley MB, Garvin J, Cairo MS. Bhatia M, et al. Among authors: van deven c. Biol Blood Marrow Transplant. 2010 Mar;16(3):333-43. doi: 10.1016/j.bbmt.2009.10.007. Epub 2009 Oct 14. Biol Blood Marrow Transplant. 2010. PMID: 19835971 Free article. Clinical Trial.

2

Circulating granulocyte colony-stimulating factor (G-CSF) levels after allogeneic and autologous bone marrow transplantation: endogenous G-CSF production correlates with myeloid engraftment.

Cairo MS, Suen Y, Sender L, Gillan ER, Ho W, Plunkett JM, van de Ven C. Cairo MS, et al. Blood. 1992 Apr 1;79(7):1869-73. Blood. 1992. PMID: 1373092 Free article.

3

Effect of stem cell factor with and without granulocyte colony-stimulating factor on neonatal hematopoiesis: in vivo induction of newborn myelopoiesis and reduction of mortality during experimental group B streptococcal sepsis.

Cairo MS, Plunkett JM, Nguyen A, van de Ven C. Cairo MS, et al. Blood. 1992 Jul 1;80(1):96-101. Blood. 1992. PMID: 1377057 Free article.

4

In vivo hematological effects of seven days of rhIL-6 in neonatal rats.

Cairo MS, Plunkett JM, Clark S, van de Ven C. Cairo MS, et al. Am J Pediatr Hematol Oncol. 1992 Spring;14(1):44-7. doi: 10.1097/00043426-199221000-00006. Am J Pediatr Hematol Oncol. 1992. PMID: 1550262

5

Seven-day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: modulation of neonatal neutrophilia, myelopoiesis, and group B Streptococcus sepsis.

Cairo MS, Plunkett JM, Mauss D, Van de ven C. Cairo MS, et al. Blood. 1990 Nov 1;76(9):1788-94. Blood. 1990. PMID: 1699622 Free article.

6

Recombinant human granulocyte-macrophage colony-stimulating factor primes neonatal granulocytes for enhanced oxidative metabolism and chemotaxis.

Cairo MS, van de Ven C, Toy C, Mauss D, Sender L. Cairo MS, et al. Pediatr Res. 1989 Nov;26(5):395-9. doi: 10.1203/00006450-198911000-00001. Pediatr Res. 1989. PMID: 2554242

7

Clinical and laboratory experience in marrow harvesting in children for autologous bone marrow transplantation.

Cairo MS, VandeVen C, Toy C, Sender L. Cairo MS, et al. Bone Marrow Transplant. 1989 May;4(3):305-8. Bone Marrow Transplant. 1989. PMID: 2659115

8

A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia.

Gillan ER, Christensen RD, Suen Y, Ellis R, van de Ven C, Cairo MS. Gillan ER, et al. Blood. 1994 Sep 1;84(5):1427-33. Blood. 1994. PMID: 7520770 Free article. Clinical Trial.

9

The combined effects of interleukin-11, stem cell factor, and granulocyte colony-stimulating factor on newborn rat hematopoiesis: significant enhancement of the absolute neutrophil count.

Cairo MS, Plunkett JM, Schendel P, van de Ven C. Cairo MS, et al. Exp Hematol. 1994 Oct;22(11):1118-23. Exp Hematol. 1994. PMID: 7523164

10

IL-11 in combination with SLF and G-CSF or GM-CSF significantly increases expansion of isolated CD34+ cell population from cord blood vs. adult bone marrow.

van de Ven C, Ishizawa L, Law P, Cairo MS. van de Ven C, et al. Exp Hematol. 1995 Nov;23(12):1289-95. Exp Hematol. 1995. PMID: 7589284

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters